author-photo

Lyudmila G. Burdelya

Roswell Park Cancer Institute

29

Papers

1851

Citations

Citation Trend

Filter By

Papers (21) Sort By

Journal Conference Others

Mitigation of Radiation-Induced Epithelial Damage by the TLR5 Agonist Entolimod in a Mouse Model of Fractionated Head and Neck Irradiation

2017 Radiation Research
Show All
- Source
- Cite
- Save
Citations (30)
Toll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8+ T-cell axis

2016 Proceedings of the National Academy of Sciences of the United States of America
Show All
- Source
- Cite
- Save
Citations (58)
Abstract B090: A Toll-like receptor 5 agonist entolimod as a potential anticancer immunotherapeutic agent

2016 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (0)
The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism

2016 Oncotarget
Show All
- Source
- Cite
- Save
Citations (31)
A phase I study of the toll-like receptor 5 (TLR5) agonist, entolimod in patients (pts) with advanced cancers.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (8)
An Agonist of Toll-Like Receptor 5 Suppresses Hepatic Metastases in a Mouse Model with Ocular Melanoma

2014 Investigative Ophthalmology & Visual Science
Show All
- Source
- Cite
- Save
Citations (0)
Toll-like receptor-5 agonist Entolimod broadens the therapeutic window of 5-fluorouracil by reducing its toxicity to normal tissues in mice

2014 Oncotarget
Show All
- Source
- Cite
- Save
Citations (27)
Activation of innate and adaptive immunity by a TLR5 agonist to prevent and suppress liver metastasis (TUM7P.947)

2014 Journal of Immunology
Show All
- Source
- Cite
- Save
Citations (0)
Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist

2013 Proceedings of the National Academy of Sciences of the United States of America
Show All
- Source
- Cite
- Save
Citations (86)
A TLR5 Agonist Enhances CD8+ T Cell-Mediated Graft-versus-Tumor Effect without Exacerbating Graft-versus-Host Disease

2012 Journal of Immunology
Show All
- Source
- Cite
- Save
Citations (23)